DiaMedica Therapeutics, Inc.
DiaMedica-Logo
Navigate DiaMedica Therapeutics, Inc.
Home
About Us
Company Overview
Leadership Team
Board of Directors
Clinical Advisory Boards
Science
Our Science
Pipeline
Diseases We Target
Overview
IgA Nephropathy
African Americans - Hypertensive with CKD
Acute Ischemic Stroke
Investors & Media
Investors Home
Press Releases
Events & Presentations
Nasdaq Stock Information
Analyst Coverage
Financial Reports
Governance
Investor Resources
Careers
Contact
Home
Investors & Media
Press Releases
Press Releases
All News
By Year:
2021
2020
2019
2018
2017
2016
Jan 11, 2021
DiaMedica Therapeutics to Present at the H.C. Wainwright BioConnect Conference
Dec 15, 2020
DiaMedica Therapeutics Announces Enrollment of Last Patient in Diabetic Kidney Disease Cohort of Phase 2 REDUX CKD Study
Dec 10, 2020
DiaMedica Therapeutics Announces Successful Type B Meeting with FDA for the Study of DM199 in Patients with Acute Ischemic Stroke
Nov 19, 2020
DiaMedica Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
Nov 11, 2020
DiaMedica Therapeutics to Participate in 11th Annual Craig-Hallum Alpha Select Conference
Nov 4, 2020
DiaMedica Provides a Business Update and Third Quarter 2020 Financial Results
Oct 28, 2020
DiaMedica Therapeutics to Report Third Quarter 2020 Financial Results and Provide a Business Update November 5, 2020
Sep 15, 2020
DiaMedica Therapeutics to Present at Lake Street’s Virtual 4th Annual (BIG4) Conference September 17, 2020
Sep 14, 2020
DiaMedica Announces First Patients Dosed in Diabetic Kidney Disease Cohort in Phase II REDUX CKD Clinical Study
Aug 11, 2020
DiaMedica Provides a Business Update and Second Quarter 2020 Financial Results
1
2
3
4
5
6
7
8
9
10
Next >>
Show All